Healthcare DIVE February 3, 2025
Susanna Vogel

Tariffs and price inflation for specialty medications will increase costs, according to research from Vizient.

Dive Brief:

  • Health supply chain costs and pharmaceutical expenses are projected to rise modestly between July 2025 and June 2026, according to new research from healthcare services company Vizient.
  • Pharmacy spend will rise 3.8%, driven in part by increased demand for specialty medications. AbbVie’s autoimmune disease drug Humira will continue to be the most popular drug by total spend, however popular GLP-1s like Ozempic, Wegovy and Mounjaro are projected to enter the top-10 list of medications by total spend.
  • Supply chain costs will rise by approximately 2% during the period, following higher prices for raw materials, increased freight and shipping costs and tariffs on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Survey / Study, Technology, Trends
Related Articles:
Drugmakers prep for bird flu outbreak, despite continued low risk
Heart health differences in men and women: Tiny RNA molecules play key role, study finds
Advancing Cancer Care: The Role of Radiopharmaceuticals in Precision Medicine
STAT+: Nobel laureates call on National Academies and biotech CEOs to speak out against Trump attacks on science
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA

Share This Article